![Sylvia R. Wheeler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sylvia R. Wheeler
Corporate Officer/Principal chez
Advances In Kidney Disease & Health
Profil
Sylvia R.
Wheeler is currently the Director-West Coast Division at Advances In Kidney Disease & Health.
Former positions include Director-Corporate Communications at Cerus Corp.
(2003), Director-Corporate Communications at Coulter Pharmaceuticals, Inc. (2000), Senior Director-Corporate Communications at Assertio Therapeutics, Inc. (2007), Director-Corporate Relations & Planning at Connetics Corp.
(1995-1997), Director-Corporate Communications at Affymax, Inc. (2010-2011), Head-Investor Relations & Corporate Communications at Mereo BioPharma 5, Inc., VP-Investor Relations & Corporate Communications at Hyperion Therapeutics, Inc. (2013-2014), Senior VP-Investor Relations & Corporate Affairs at Aduro BioTech, Inc., VP-Investor Relations & Corporate Affairs at Relypsa, Inc., Investor Contact Relations at Immune Design Corp., and Investor Relations Contact at Rapt Therapeutics, Inc. Education includes undergraduate studies at San Francisco State University and an MBA from the University of San Francisco.
Postes actifs de Sylvia R. Wheeler
| Sociétés | Poste | Début |
|---|---|---|
Advances In Kidney Disease & Health
 Advances In Kidney Disease & Health Miscellaneous Commercial ServicesCommercial Services Provides awareness on kidney and urinary tract diseases | Corporate Officer/Principal | - |
Anciens postes connus de Sylvia R. Wheeler
| Sociétés | Poste | Fin |
|---|---|---|
| RAPT THERAPEUTICS, INC. | Investor Relations Contact | 03/03/2026 |
| IMMUNE DESIGN CORP | Investor Relations Contact | 02/04/2019 |
| HYPERION THERAPEUTICS INC | Investor Relations Contact | 03/04/2014 |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Public Communications Contact | 01/01/2007 |
| CERUS CORPORATION | Public Communications Contact | 01/01/2003 |
Formation de Sylvia R. Wheeler
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Cerus Corp.
 Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
Coulter Pharmaceuticals, Inc.
 Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs and therapies for treatment of cancer | Health Technology |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | Health Technology |
Mereo BioPharma 5, Inc.
 Mereo BioPharma 5, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer stem cell therapeutics | Health Technology |
Hyperion Therapeutics, Inc.
 Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Aduro BioTech, Inc.
 Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company, which focuses on the development of technology platforms for cancer | Health Technology |
Affymax, Inc.
 Affymax, Inc. BiotechnologyHealth Technology Develops and distributes pharmaceutical products | Health Technology |
San Francisco State University
 San Francisco State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of San Francisco
 University of San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Advances In Kidney Disease & Health
Advances In Kidney Disease & Health Miscellaneous Commercial ServicesCommercial Services Provides awareness on kidney and urinary tract diseases | Commercial Services |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and clinical-stage immunotherapy company | Health Technology |
Rapt Therapeutics, Inc.
 Rapt Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oral small molecule therapies for patients | Health Technology |
